Capital World Investors
IMGN

Capital World Investors’s Immunogen Inc IMGN Stock Holding History

Capital World Investors’s Portfolio IMGN Stock Details IMGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q3 		– Sell
-950,000
Closed -$9.24M – 600
2018
Q2 		$9.24M Buy
+950,000
New +$10M ﹤0.01% 500

Other funds holding IMGN

RG
Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

Capital World Investors's IMGN Position: Q3 2018 in Review

Capital World Investors sold out of Immunogen Inc (IMGN) in Q3 2018, closing a stake of 950,000 shares — an estimated $9.24M sold.

Capital World Investors first reported a position in IMGN in Q2 2018 and held it in 1 quarter. The position peaked at $9.24M in Q2 2018. 208 funds tracked by Wall St. Rank hold IMGN as of Q3 2018.

  • Capital World Investors reported no remaining Immunogen Inc position as of Q3 2018 after selling out during the quarter.
  • Capital World Investors sold 950,000 Immunogen Inc shares in Q3 2018, an estimated $9.24M.
  • Capital World Investors first reported a position in Immunogen Inc in Q2 2018 and held it in 1 quarter.
  • Capital World Investors's Immunogen Inc position peaked at $9.24M in Q2 2018.
  • 208 funds tracked by Wall St. Rank held Immunogen Inc as of Q3 2018.

Based on Capital World Investors's 13F filing for Q3 2018, filed 14 Nov 2018.